HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Yamaguchi Selected Research

Polysaccharides (Glycans)

3/2016Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer.
9/2000Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Yamaguchi Research Topics

Disease

28Neoplasms (Cancer)
03/2016 - 01/2000
9Hemorrhage
12/2010 - 10/2000
6Inflammation (Inflammations)
10/2020 - 06/2001
6Wounds and Injuries (Trauma)
04/2010 - 10/2001
6Type 2 Diabetes Mellitus (MODY)
01/2008 - 01/2000
5Proteinuria
02/2010 - 06/2000
5Chronic Hepatitis C
03/2004 - 01/2000
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018 - 08/2014
4Stomach Neoplasms (Stomach Cancer)
03/2016 - 09/2000
4Necrosis
07/2011 - 11/2003
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2006 - 01/2000
3Breast Neoplasms (Breast Cancer)
12/2019 - 06/2003
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2010 - 01/2000
3Infections
11/2001 - 12/2000
3Atherosclerosis
05/2001 - 01/2000
3Glomerulonephritis
01/2001 - 11/2000
3Ischemia
12/2000 - 01/2000
3Reperfusion Injury
12/2000 - 01/2000
2Obesity
10/2020 - 01/2004
2Pain (Aches)
01/2017 - 02/2015
2Rheumatoid Arthritis
01/2016 - 04/2005
2Colonic Neoplasms (Colon Cancer)
11/2015 - 10/2000
2Lung Neoplasms (Lung Cancer)
08/2015 - 02/2015
2Atopic Dermatitis (Atopic Eczema)
08/2014 - 03/2011
2Systemic Scleroderma (Systemic Sclerosis)
04/2013 - 04/2005
2Nephrotic Syndrome (Syndrome, Nephrotic)
11/2010 - 07/2000
2Insulin Resistance
02/2010 - 01/2000
2Hypoglycemia (Reactive Hypoglycemia)
02/2010 - 01/2000
2Hematuria
01/2010 - 06/2001
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2010 - 05/2000
2Aspiration Pneumonia
01/2007 - 02/2006
2Ulcer
06/2005 - 11/2004
2Blister (Bulla)
04/2005 - 11/2004
2Neoplasm Metastasis (Metastasis)
07/2004 - 09/2000
2Obstructive Sleep Apnea
01/2004 - 08/2001
2Colorectal Neoplasms (Colorectal Cancer)
11/2003 - 10/2000
2Hepatitis
07/2001 - 06/2000
2Pancreatitis
01/2001 - 08/2000

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
02/2016 - 06/2000
7InterleukinsIBA
03/2011 - 08/2000
5AutoantibodiesIBA
01/2020 - 01/2000
5CytokinesIBA
08/2014 - 01/2000
5EnzymesIBA
08/2014 - 04/2000
5Insulin (Novolin)FDA Link
03/2006 - 01/2000
4Immunoglobulin A (IgA)IBA
01/2014 - 01/2001
4Complementary DNA (cDNA)IBA
05/2010 - 06/2003
4AntibodiesIBA
02/2010 - 09/2001
4Interleukin-2 (IL2)IBA
04/2006 - 08/2000
4InterferonsIBA
03/2004 - 01/2000
3Interleukin-6 (Interleukin 6)IBA
10/2020 - 11/2003
3Anti-Bacterial Agents (Antibiotics)IBA
01/2018 - 11/2004
3Biological ProductsIBA
02/2015 - 01/2000
3ImmunosorbentsIBA
08/2014 - 01/2001
3CreatinineIBA
07/2011 - 01/2001
3Transforming Growth Factors (Transforming Growth Factor)IBA
11/2010 - 05/2001
3Glucose (Dextrose)FDA LinkGeneric
02/2010 - 01/2000
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2006 - 08/2001
3Messenger RNA (mRNA)IBA
02/2001 - 07/2000
3Chemotactic FactorsIBA
12/2000 - 01/2000
2LeptinIBA
10/2020 - 01/2003
2Toll-Like Receptor 4IBA
01/2018 - 09/2015
2Biomarkers (Surrogate Marker)IBA
06/2016 - 04/2013
2Cadherins (E-Cadherin)IBA
03/2016 - 02/2016
2Polysaccharides (Glycans)IBA
03/2016 - 09/2000
2Adalimumab (Humira)FDA Link
01/2016 - 02/2015
2TegafurIBA
11/2015 - 09/2000
2ErbB Receptors (EGF Receptor)IBA
09/2015 - 02/2015
2Epidermal Growth Factor (EGF)IBA
08/2015 - 02/2015
2Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
08/2015 - 02/2015
2AgarIBA
02/2015 - 06/2001
2PeriostinIBA
08/2014 - 04/2013
2Uric Acid (Urate)IBA
04/2012 - 07/2011
2CollagenIBA
11/2010 - 01/2000
2Pharmaceutical PreparationsIBA
11/2010 - 05/2000
2Insulin ReceptorIBA
02/2010 - 01/2000
2B-insulinIBA
02/2010 - 01/2000
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2010 - 01/2000
2SteroidsIBA
01/2010 - 06/2001
2Hemoglobins (Hemoglobin)IBA
10/2006 - 08/2001
2LipidsIBA
02/2006 - 01/2000
2Capsules (Microcapsules)IBA
07/2004 - 01/2004
2Estrogens (Estrogen)FDA Link
06/2004 - 06/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2004 - 08/2000
2PicibanilIBA
11/2003 - 10/2000
2Ethanol (Ethyl Alcohol)IBA
01/2003 - 07/2001
2Phosphates (Orthophosphate)IBA
01/2003 - 01/2000
2DNA (Deoxyribonucleic Acid)IBA
11/2001 - 01/2000
2Oxidants (Oxidizing Agents)IBA
05/2001 - 01/2000
2LectinsIBA
05/2001 - 01/2001
2Dacarbazine (DIC)FDA LinkGeneric
04/2001 - 10/2000

Therapy/Procedure

19Therapeutics
01/2011 - 01/2000
4Occlusive Dressings (Occlusive Dressing)
04/2005 - 10/2001
3Adjuvant Chemotherapy
11/2015 - 09/2000
3Aftercare (After-Treatment)
01/2010 - 11/2000
3Topical Administration
02/2006 - 10/2001
3Immunotherapy
11/2003 - 10/2000
2Bed Rest (Bedrest)
04/2005 - 11/2004
2Debridement
04/2005 - 11/2004
2Surgical Amputation (Amputations)
04/2005 - 11/2004
2Kidney Transplantation
03/2001 - 01/2001